Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome

International Journal of Cardiology

Volumn 95, Issue 2-3, 2004, Pages 261-268

  Izumida, Naomi ^a   Asano, Yuh ^a   Doi, Shouzaburoh ^a   Wakimoto, Hiroko ^a   Fukamizu, Seiji ^b   Kimura, Takuro ^b   Ueyama, Tsuyoshi ^b   Sakurada, Harumizu ^b   Kawano, Seiko ^c   Sawanobori, Tohru ^d   Hiraoka, Masayasu ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d Medical Research Institute   (Japan)

Author keywords

Body surface map; Brugada syndrome; Depolarization; Repolarization; ST elevation

Indexed keywords

ISOPRENALINE; SODIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; BODY SURFACE; BRUGADA SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART CONDUCTION; HEART DEPOLARIZATION; HEART REPOLARIZATION; HUMAN; MALE; PRIORITY JOURNAL; QRS COMPLEX; ST SEGMENT ELEVATION; SURFACE PROPERTY;

ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ARRHYTHMIA AGENTS; BODY SURFACE POTENTIAL MAPPING; BUNDLE-BRANCH BLOCK; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; SYNDROME; VENTRICULAR FIBRILLATION;

EID: 2942610914     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.05.025     Document Type: Article

References (30)

1. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 20:1992;1391-1396
2. Brugada J., Brugada R., Brugada P. Right bundle-blanch and ST-segment elevation in leads V1 through V3. A marker of sudden death in patients without demonstrable structural heart disease. Circulation. 97:1998;457-460
3. Gussak I., Antzelevitch C., Bjerregaard P., Towbin J.A., Chaitman B.R. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J. Am. Coll. Cardiol. 33:1999;5-15
4. Atarashi H., Ogawa S., Harumi K., et al. Characteristics of patients with right bundle branch block and ST segment elevation in right precordial leads. Am. J. Cardiol. 78:1996;581-583
5. Alings M., Wilde A. "Brugada" syndrome. Clinical data and suggested pathophysiological mechanisms. Circulation. 99:1999;666-673
6. Kasanuki H., Ohnishi S., Ohtuka M., et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation. 95:1997;2277-2285
7. Roden D.M., Wilde A.A.M. Drug-induced J point elevation: a marker for genetic risk of sudden death or ECG curiosity? J. Cardiovasc. Electrophysiol. 10:1999;214-218
8. Miyazaki T., Mitamura H., Miyoshi S., Soejima K., Aizawa Y., Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J. Am. Coll. Cardiol. 27:1996;1061-1070
9. Fujiki A., Usui M., Nagasawa H., Mizumaki K., Hayashi H., Inoue H. ST segment elevation in the right precordial leads induced with class Ic antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. J. Cardiovasc. Electrophysiol. 10:1999;214-218
10. Brugada R., Brugada J., Antzelevitch C., et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 101:2000;510-515
11. Yasuda M., Nakazato Y., Yamashita H., et al. ST segment elevation in the right precordial leads following administration of class Ic antiarrhythmic drugs. Heart. 85:2001;e3
12. Yan G.X., Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanism of arrhythmogenesis associated with ST segment elevation. Circulation. 100:1999;1660-1666
13. Yamada K. Body surface isopotential map. Past, present and future. Jpn. Circ. J. 45:1981;1-14
14. Bruns H., Eckardt L., Vahlhaus C., et al. Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads. Cardiovasc. Res. 54:2002;58-66
15. Wakimoto H., Izumida N., Asano Y., et al. Augumentation of QRS wave amplitudes in the precordial leads during narrow QRS tachycardia. J. Cardiovasc. Electrophysiol. 11:2000;52-60
16. Abildskov J.A., Evans A.K., Lux R.L., Burges M.J. Ventricular recovery properties and QRST deflection area in cardiac electrograms. Am. J. Physiol. 239:1980;H227-231
17. Abildskov J.A., Green L.S., Evans A.K., Lux R.L. The QRST deflection area of electrogram during global alterations of ventricular repolarization. J. Electrocardiol. 15:1982;103-108
18. Izumida N., Kiyohara K., Asano Y., et al. The body surface QRST isointegral maps in infants with right ventricular overload. Jpn. Circ. J. 57:1993;123-130
19. Haws C.W., Lux R.L. Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms. Circulation. 81:1990;281-288
20. Izumida N., Asano Y., Wakimoto H., et al. Analysis of T wave changes by activation recovery interval in patients with atrial septal defect. Int. J. Cardiol. 72:2000;115-124
21. The Japanese Circulation Society Task Force Committee on Criteria for Body Surface Mapping. Data base for body surface potential maps of normal populations. Yasui S. Clinical body surface mapping and high resolution electrocardiography. 1994;262 Life Medicom, Nagoya
22. Day C.P., McComb J.M., Campbell R.W.F. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br. Heart J. 63:1990;342-344
23. Yamaki M., Kubota I., Endo T., Hosoya Y., Ikeda K., Tomoike H. Relation between recovery sequence estimated from body surface potentials and T wave shape in patients with negative T waves and normal subjects. Circulation. 85:1992;1768-1774
24. Akahoshi M., Hirai M., Inden Y., et al. Body-surface distribution of changes in activation-recovery intervals before and after catheter ablation in patients with Wolff-Parkinson-White syndrome: clinical evidence for ventricular "electrical remodeling" with prolongation of action-potential duration over a preexcited area. Circulation. 96:1997;1566-1574
25. Shimizu W., Antzelevitch C., Suyama K., et al. Effect on sodium channel blockers on ST segment, QRS duration, corrected QT interval in patients with Brugada syndrome. J. Cardiovasc. Electrophysiol. 11:2000;1320-1329
26. Peeters H.A.P., Sippengroenewegen A., Wever E.F.D., et al. Electrocardiographic identification of abnormal ventricular depolarization and repolarization in patients with idiopathic ventricular fibrillation. J. Am. Coll. Cardiol. 31:1998;1406-1413
27. Kuo C.S., Munakata K., Reddy P., Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation. 67:1983;1356-1367
28. Zabel M., Portnoy S., Franz M.R. Electrocardiographic indexes of dispersion of ventricular repolarization: a isolated heart validation study. J. Am. Coll. Cardiol. 25:1995;746-752
29. Inden Y., Hirai M., Takada Y., et al. Prolongation of activation-recovery interval over a preexcited region before and after catheter ablation in patients with Wolff-Parkinson-White syndrome. J. Cardiovasc. Electrophysiol. 12:2001;939-945
30. Corrado D., Basso C., Buja G., Nava A., Rossi L., Thiene G. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation. 103:2001;710-717